chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine on 1-14-03; Adverse events: 1-19-03,01-20-03 sore throat, swollen lymph nodes, malaise, 01-27-03 viral throat ulcers; 01-27-03 malaise and fever, took Tylenol and prescribed lido/vsc; 02-03-03 sore throat, 02-5-03 left vaccine arm very sore unable to raise arm over head, node between left thumb & index finger sore; 02-07-03 scab fell off, temp of 100.2, malaise took Tylenol; 0208/ 02-09-03 joint pain, malaise, diagnosed w/ bacterial throat infection, 02-10-03 sore throat, neck, joints, chills dry cough, and temp 101.02 prescribed endocet. 02-11-03 thru 2-13-03 fevers between 102.7 to 103.01, cough joint pain, chills vomiting; on 02-13-03 addmitted to Hospital for bi-pneumonia, antibiotics and steroids administerd; had steroid induced diabetes which went away after stopped steroids; discharged 02-18-03; 02-21-03 sore throat and thrush; fevers 02-24-03, sore throat 02-25-03, fever and left knee, and hip swollen 02-26-03 thru 02-26-03; relapse 03-07-03 readmitted to hosp w/bi-pneumonia; discharged 03-19-03 no fever; but fevers resumed 04-07-03 thru 04-10-03; referred to Lung Specialist, put on Prednisone 10mg to control fevers, ana up, sed rate up, crp up, fluid on lungs; fevers again 05-22-03 thru 05-24-03 Prednisone upped to 20mg, developed shortness of breath upon exertion; fluid cleared 05-22-03; bottom part of lungs have stopped expanding; Referred to rheumatologist, ana negative but other tests positive, vaccine seems to have triggered lupus; will need lung biopsy to verify; (WILL BE scheduled in late June) Unable to work Prednisone increased to 40mg then 60mg daily, lower bases of lungs hurt; have had 2 lung infections in 5-03, re-occurring Pleurisy, shortness of breath increasing, hair shedding, aches, malaise.
no adverse effects reported; one dose of improperly stored MMR II as inadvertenlty administered to the one patient; This spontaneous report as received from a medical assistant refers to a 12-year-old patient of an unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 16-OCT-2019, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot # R028003, expiration date 01-OCT-2020, for prophylaxis (dose, frequency, route of administration and anatomical location were not provided), which was reconstituted with properly stored sterile diluent. The vaccine was exposed to temperature of 52 degrees Fahrenheit for 10 hours. The call was made because of digital data logger. There were no previous temperature excursion. There were no adverse effects reported.
Pt became nauseated around 7 pm last night after she went home. Went to sleep. Woke up around 10:30 pm with stiff neck and severe aching on neck, head and shoulders. Site is sore with red lump present. Woke up this AM with diarrhea once and vomited x 3. Denies fever. Severe aching. Pain 6/10.
Arm was sore at then 12 hours after vaccination chills, fever of 102.5, headache and achy began. This lasted for 8 hours.
Sore at inj site for 3 days; This is a spontaneous report from a contactable Nurse (patient). A 49-year-old female patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration, in left deltoid on 01Feb2021 as single dose for covid-19 immunisation. Medical history included vestibular migraine from 24May2017 and ongoing, PCN allergy from 01Jun2012 and ongoing, ragweed allergy from 10Oct2017 and ongoing. Concomitant medications included allopurinol (ELAVIL) via oral from unknown date in 2017 and ongoing at 10 mg, daily for vestibular migraines and propranolol via oral from 12Aug2020 and ongoing at 60 mg, daily for Vestibular migraine. The patient historical medication included first dose of BNT162B2 (at the age of 49-year-old) Lot number: EL0142, (IM injection) time vaccination was given: 12:50 (24-hour clock) on 08Jan2021 for covid-19 immunisation and experienced Sore arm inj site, diarrhea (event onset date and time of onset (24 hr clock): 09Jan2021; 22:00), Migraine, vertigo (event onset date and time of onset (24 hr clock): 10Jan2021; 14:30) and dizziness (After vertigo attack, increase dizziness persisted resulting in EMLA/LOA from work) and acetaminophen (Most recent dose: x 1 dose 1000mg oral) for Premedicated before vaccine. The patient experienced sore at inj site for 3 days on Feb2021. The outcome of the event was unknown. Reporter considered that the Pfizer product had a casual effect to the adverse event.  Information on the lot/batch number has been requested.
Pink eye (conjunctivitis) in left eye. No treatment sought yet. Began the morning after the day of vaccination and has lasted for over 24 hours (at time of report, it has been approx. 30 hours since first sign of pink eye)
hyperthyroidism; irregular heartbeats; can't eat; constant GI issues; weigh less than 100 pounds because I am so sick all the time; weigh less than 100 pounds because I am so sick all the time; first dose received on 01May2021 at 06:30/Second dose received on 01May2021; first dose received on 01May2021 at 06:30/Second dose received on 01May2021; This is a spontaneous report from a contactable Other HCP. This 34-year-old female Other HCP (patient) reported for self. A 34-years-old (non-pregnant) female patient received first dose of bnt162b2 (COMIRNATY, solution for injection, Lot Number: EW6179 and Expiry date was not reported) dose 1 via an unspecified route of administration in arm right on 01May2021 at 06:30 (age at vaccination was 34-years-old) as dose 1, single and dose 2 via an unspecified route of administration in arm right on 01May2021 (Lot Number: EW0186 and Expiry date was not reported) as dose 2, single dose for COVID-19 immunisation. The patient was not pregnant at time of vaccination. The patient had known allergies with Zoloft. Medical history included arthritis in low back and neck from an unknown date and unknown if ongoing, covid-19 from an unknown date and unknown if ongoing. The patient had COVID prior vaccination and had not COVID tested post vaccination. Concomitant medications included in two weeks was paracetamol (TYLENOL), xylometazoline hydrochloride (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccines in four weeks. The patient previously took zoloft and experienced drug hypersensitivity. First dose received on 01May2021 at 06:30 / Second dose received on 01May2021. The patient reported, since receiving her vaccination, on 29May2021, she has been diagnosed with hyperthyroidism, she has been having irregular heartbeats, can't eat, constant GI issues, and now weigh less than 100 pounds because she was so sick all the time. The patient has been to the Emergency Room since, her primary doctor, and now the endocrinologist. AE resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included heart rate: irregular on 29May2021. Treatment received for the events. For AE treatment they are still trying to figure it out. Outcome of the events was not recovered.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the event hyperthyroidism cannot be excluded   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
This case was reported by a consumer via call center representative and described the occurrence of seizure in a infant male patient who received DTPA vaccine. On an unknown date, the patient received DTPA vaccine (intramuscular). On an unknown date, less than a year after receiving DTPA vaccine, the patient experienced seizure (serious criteria GSK medically significant), fever, limbs stiffness and appetite absent. On an unknown date, the outcome of the seizure, fever, limbs stiffness and appetite absent were unknown. It was unknown if the reporter considered the seizure, fever, limbs stiffness and appetite absent to be related to DTPA vaccine. Additional details were provided as follows: The caller (mother of the patient) reported that her son had received DTPA. In 2014, the patient received DTPA. In 2014, the patient experienced seizure, fever, limbs stiffness and decreased appetite.
first Pfixer covid 19 vax lot number FD8448 GIVEN ON 8/28/21     9/19/2021 received second  PFIZER COVID vax LOT FF8839 and in feb 2022 started having chest pains. no history of heart issues in our family.  he was sent  to a cardiologist who performed a stress test and EKG on 3/10/2022 he failed his stress test and ekg. the cardiologist scheduled a heart cath be done the next morning 3/11/2022.   the heart cath was done and they found multiple blockages in the arteries of his heart.  no heart issues ever found in prior medical records. one out of surgery his heart stopped they preformed CPR and got a heart beat.   it stopped again and they put him on ECMO till i could get to the hospital.    the death certificate states immediate cause was Cardiogenic Shock 5 hours between onset and death and myocardial infarction 7 hours between onset and death
fever chills, aches, malise, fatigue, headache starting the following morning and ongoing for about 48 hours.
This case was reported by a healthcare professional, via a GSK sales representative, and described the occurrence of pain in whole arm in a 61-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). Concurrent medical conditions included eye stye. On 10 October 2011 the subject received a dose of FLUARIX (.5 ml, intramuscular, left arm). On 10 October 2011, less than one day after vaccination with FLUARIX, the subject experienced pain in whole left arm. The subject reported that the pain was through her entire arm and had gotten worse. She was trying to obtain therapy for her arm. At the time of reporting the event was worse. Follow-up information was received from the healthcare professional on 19 December 2011: The event resolved on 15 November 2011. The healthcare professional confirmed that the event was not considered serious. No diagnostic tests, investigations or procedures were performed. The subject was offered to proceed with physical therapy, but informed the healthcare professional that "with the business of the holidays can't fit it in". The healthcare professional considered that the events were not associated with medical history or a concurrent condition, lack of efficacy, erroneous administration or suspected transmission of an infectious agent via a medicinal product. The healthcare professional considered that the events may have been caused by tai chi, which was started the same time as the subject received FLUARIX.
We keep smelling/tasting this funk; We keep smelling/tasting this funk; This is a spontaneous report received from a contactable consumer via a medical information team. A patient of unknown age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: unknown and Expire Date: unknown) via unspecified route of administration on an unspecified date as single dose for Covid-19 immunization. Patient medical history and concomitant medications were not reported. After vaccination, the patient experienced keep smelling/tasting this funk, or something rotten patient can't really explain on an unspecified date. Patient smell it randomly could be a bagel or egg or myself. The outcome of events was recovering.   Follow-up attempts are needed; information about lot/batch number requested.
anxiety Narrative:  Veteran received injection in Left arm. Veteran notified monitoring staff of headache in forehead and dizziness stating "this is new since my injection." Veteran states they have anxiety due to PTSD and feels the new symptoms may be anxiety related but want additional monitoring just to be sure. Vet states "I have not left the house since last March." "I have PTSD, I feel this anxiety related but just want to make sure. Initial VS: 1343 BP: 148/92 HR: 68 RR: 18 PN: 01/10 SO2: 99% Veteran states "that is high blood pressure for me. Usually it is too low due to the medications I take for my anxity/PTSD." F/U VS:1400 BP:129/91 HR: 71 PN:01/10 SO2: 100% Pain 01/10-Headache middle of forehead-no change. Vet states "I think its anxiety." Declined Hot/Ice pack Agreed to a juice pouch. Declined EMS Veteran departed Vaccine Clinic. /es/ RN, BSN Signed :03/18/2021 14:53
Approximately one month after the second dose of the Pfizer vaccine, I began experiencing serious symptoms of what seemed to be "allergies" to my long-time thyroid medication.  I wasn't able to tolerate my long-time thyroid medication and experienced symptoms of "overdose" such as slurred speech, burning tongue/lips/gums/nostrils, pouring eyes, roaring/ringing ears, significant vision changes, dizziness, brain fog, fine/gross motor incoordination, auditory/visual overstimulation. Thyroid tests showed extreme hyperthyroidism approaching thyroid storm- then dramatic drop into severe hypOthyroidism 9 days later.  Ten months later it was found that I had developed Covid vaccine-induced mast cell activation resulting in extreme chemical sensitivity.
Information has been received from a consumer concerning her 15 year old daughter who on 02-JUL-2008, was vaccinated with her third dose of GARDASIL. Soon after receiving her third dose, the patient experienced nausea, fatigue, headaches and dizziness. The patient sought medical attention at pediatrician's office and unspecified blood work was performed. Her symptoms persisted. Additional information has been requested.
Mom came to office on 5/9/00. Post vax, day after, thighs swollen, red with rash, swelling and redness resolved on 5/7/00 but papular rash persisted. On exam, happy alert infant NAD. Both legs appeared normal in size & color. Both legs, at site of injection nodule, scattered papular rash surrounding all three sites. Mother said this happened with first set on 3/21 but did not tell us.
suspected vaccination failure; I have had this two dose vaccine but am having an outbreak; This case was reported by a consumer via Shingrix Chatbot and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient was reporting for him/herself. The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. After receiving 2 doses of Shingrix, the patient had shingels outbreak. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation were not provided.
Patient experience rash around injection site one week after receiving first dose in series. Rash lasted for 3 to 4 days.
ZOSTAVAX given at 9:25 AM, Patient returned at 12:30 PM with a red, swollen arm, complaining of itching and a nagging cough. Patient given an Epipen dose (0.3 mg) in left thigh.
Urticarial lesions noted on legs, feet and one on face by parents and MA within 2 minutes of all vaccines. Pt observed and no new lesions noted after 15 minutes.
Patient experienced a rash, bruising, and swelling several days after the injection. She reported it to her doctor.
Patient was brought in by mom and stated that his arm was hurting. Patient's left & right arm had a red wheal. Patient was not feverish and mom stated he had not been feverish. Mom stated patient did not have any other symptoms other than his arm hurting and the redness.
This case was reported by a healthcare professional via sales representative and described the occurrence of insomnia in a female subject aged between 60 and 69 years old who was vaccinated with influenza vaccine (manufacturer unspecified). On 19 November 2012 the subject received unspecified dose of influenza vaccine (unknown). On 19 November 2012, less than one day after vaccination with influenza vaccine, the subject experienced insomnia, muscle weakness and nonspecific reaction. The sales representative was notified by the healthcare professional who is also the subject, of an adverse events related to a flu vaccine. The subject received the vaccine and she was not certain if she received GSK vaccine or not. The subject stated that she developed a severe reaction after receiving a flu vaccine. The side effect eventually resolved after many months, specific dates were unknown. The sales representative did not have specific details to report. At the time of reporting the events were resolved.
This spontaneous report was received from a healthcare worker referring to an unspecified patients of unknown age and gender. On an unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II (dose, frequency and route of administration were not reported, lot # reported as L027432 with expiration date: 27-JUL-2017, L015282 with expiration date: 30-APR-2017). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
I came down with a COVID infection; I came down with a COVID infection; This is a spontaneous report from a contactable healthcare professional (HCP) reporting for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number not reported) via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient came down with a COVID infection on 23Dec2020 with outcome of unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event "came down with a COVID infection" based on the known safety profile. However the short duration of 5 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.
About seven hours after I received the second vaccine I had migraine headache foggy feeling in my head a little bit of achiness, same thing the following day not as bad. Two days after the shot I am feeling fine
Starting about 7/30/21 fever, emesis and diarrhea.  Then developed dyspnea and cough.  Then developed neurological symptoms including weakness, parasthesias, diaphragmatic and respiratory muscle involvement, hypertensive urgency and dysautonomia.  Hospitalized at Neuro ICU.
pt devel t>105 & unconsolible crying 14JAN94 p/recvd vax; parents gave pt cold bath x 1 & APAP x 2 days;
Patient went for his second dose on 09-March-2021 and when Pharmacist saw his allergic reaction he did not give him vaccine and said that he might get even worse anaphylactic reaction; Rash on Chest, back, one leg, both arms; rash was very itchy; rash was  pink in color; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash was very itchy), RASH ERYTHEMATOUS (rash was  pink in color), INTENTIONAL DOSE OMISSION (Patient went for his second dose on 09-March-2021 and when Pharmacist saw his allergic reaction he did not give him vaccine and said that he might get even worse anaphylactic reaction) and RASH (Rash on Chest, back, one leg, both arms) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Type I diabetes mellitus.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced RASH PRURITIC (rash was very itchy), RASH ERYTHEMATOUS (rash was  pink in color) and RASH (Rash on Chest, back, one leg, both arms). On an unknown date, the patient experienced INTENTIONAL DOSE OMISSION (Patient went for his second dose on 09-March-2021 and when Pharmacist saw his allergic reaction he did not give him vaccine and said that he might get even worse anaphylactic reaction). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (rash was very itchy), RASH ERYTHEMATOUS (rash was  pink in color) and RASH (Rash on Chest, back, one leg, both arms) had not resolved and INTENTIONAL DOSE OMISSION (Patient went for his second dose on 09-March-2021 and when Pharmacist saw his allergic reaction he did not give him vaccine and said that he might get even worse anaphylactic reaction) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-Mar-2021: Additional information included lot number
Pt recvd vax & was unable to walk on lt leg; did not given any further info; recvd info from hosp report indicates that pt was unable to walk for 5 mins;
01/24/22 presents to ED for "Shortness of Breath". PMHx of "OSA, asthma and uncontrolled hypertension"
pain developed on the upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain developed on the upper arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 03-Feb-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain developed on the upper arm). At the time of the report, VACCINATION SITE PAIN (pain developed on the upper arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to INC.-MOD-2021-064212 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. INC.-MOD-2021-064212:Linked with first dose case
Positive pertussis.  Follow-up- Hep A and TDaP vaccine manufacturer provided. Record updated.
6/19 4" X 4 1/2 " area on right arm, hot, erythema, raised.  Size increased next day but color tone duller.  Ibuprofen 600 mg po tid with food X 7d.  Ice local application.  Discouraged use of right arm X 1 week.
Pt developed rash the day after HPV vaccine and mom was sure it was from the Gardasil. To me and to the Dermatologist I consulted, it looked more like a bug bite hypersensitivity. Since that diagnosis is not certain and it occurred 24 hours after the vaccination, this is being reported. HE ALSO got Menactra  LOT # U5869AB made by Sanofi that day, It was his first Menactra
Chills without fever, drowsiness but unable to sleep, and a lump at the injection site.